(Q78213010)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Transmission of antiretroviral-drug-resistant HIV-1 variants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

S Yerly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

L Kaiser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

E Race

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J P Bru

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

F Clavel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

L Perrin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

9180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

729-733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Impact of drug resistance mutations on virologic response to salvage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

HIV-1 Reverse Transcription A Termination Step at the Center of the Genome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Maintaining the integrity of human immunodeficiency virus sequence databases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2912262-6

7 January 2021

10.1016/S0140-6736(98)12262-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10475184%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference